IFP Advisors’s Arbutus Biopharma ABUS Stock Holding History

IFP Advisors’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	–	–	3132
2025 Q1	–	Hold	0	–	–	–	3672
2024 Q4	–	Hold	0	–	–	–	3780
2019 Q1	–	Sell	-10	Closed	–	–	2346
2018 Q4	$0	Hold	10	–	–	﹤0.01%	3492
2018 Q3	$0	Hold	10	–	–	﹤0.01%	3796
2018 Q2	$0	Hold	10	–	–	﹤0.01%	3850
2018 Q1	$0	Hold	10	–	–	﹤0.01%	3733
2017 Q4	$0	Sell	10 -350	-97%	-$2.05K	﹤0.01%	3783
2017 Q3	$2K	Hold	360	–	–	﹤0.01%	3712
2017 Q2	$1K	Hold	360	–	–	﹤0.01%	3844
2017 Q1	$1K	Hold	360	–	–	﹤0.01%	3764
2016 Q4	$1K	Buy	360 +350	+3,500%	+$1.02K	﹤0.01%	3742
2016 Q3	$0	Sell	10 -100	-91%	-$391	﹤0.01%	3879
2016 Q2	$0	Buy	+110	New	+$466	﹤0.01%	3808
2016 Q1	–	Sell	-110	Closed	–	–	2342
2015 Q4	$0	Buy	+110	New	+$603	﹤0.01%	3701

Other funds holding ABUS

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BCP

BlackBarn Capital Partners New York $1.19B AUM 63.92% 1-Year Est. Return

IFP Advisors's ABUS Position: Q2 2025 in Review

IFP Advisors held its Arbutus Biopharma (ABUS) position steady in Q2 2025 at 0 shares worth $7.04K. The position accounts for ﹤0.01% of the portfolio, ranked #3132.

IFP Advisors first reported a position in ABUS in Q4 2015 and has held it in 12 quarters since. The position peaked at $2K in Q3 2017. 162 funds tracked by Wall St. Rank hold ABUS as of Q2 2025.

IFP Advisors held 0 shares of Arbutus Biopharma worth $7.04K as of Q2 2025.
IFP Advisors left its Arbutus Biopharma share count unchanged in Q2 2025.
Arbutus Biopharma made up ﹤0.01% of IFP Advisors's portfolio in Q2 2025, its #3132 holding.
IFP Advisors first reported a position in Arbutus Biopharma in Q4 2015 and has held it in 12 quarters since.
IFP Advisors's Arbutus Biopharma position peaked at $2K in Q3 2017.
162 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.